Meryl Brod, Torsten Christensen, Trine L Thomsen, Donald M Bushnell. Value Health 2011
Times Cited: 186
Times Cited: 186
Times Cited
Times Co-cited
Similarity
Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.
Elizabeth R Seaquist, John Anderson, Belinda Childs, Philip Cryer, Samuel Dagogo-Jack, Lisa Fish, Simon R Heller, Henry Rodriguez, James Rosenzweig, Robert Vigersky. Diabetes Care 2013
Elizabeth R Seaquist, John Anderson, Belinda Childs, Philip Cryer, Samuel Dagogo-Jack, Lisa Fish, Simon R Heller, Henry Rodriguez, James Rosenzweig, Robert Vigersky. Diabetes Care 2013
25
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N Engl J Med 1993
20
Self-reported non-severe hypoglycaemic events in Europe.
C G Östenson, P Geelhoed-Duijvestijn, J Lahtela, R Weitgasser, M Markert Jensen, U Pedersen-Bjergaard. Diabet Med 2014
C G Östenson, P Geelhoed-Duijvestijn, J Lahtela, R Weitgasser, M Markert Jensen, U Pedersen-Bjergaard. Diabet Med 2014
18
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
. Diabetologia 2007
. Diabetologia 2007
17
Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries.
Marc Evans, Kamlesh Khunti, Muhammad Mamdani, Claus B Galbo-Jørgensen, Jens Gundgaard, Mette Bøgelund, Stewart Harris. Health Qual Life Outcomes 2013
Marc Evans, Kamlesh Khunti, Muhammad Mamdani, Claus B Galbo-Jørgensen, Jens Gundgaard, Mette Bøgelund, Stewart Harris. Health Qual Life Outcomes 2013
17
Costs of managing severe hypoglycaemia in three European countries.
Mette Hammer, Morten Lammert, Susana Monereo Mejías, Werner Kern, Brian M Frier. J Med Econ 2009
Mette Hammer, Morten Lammert, Susana Monereo Mejías, Werner Kern, Brian M Frier. J Med Econ 2009
16
16
Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.
. Diabetes Care 2005
. Diabetes Care 2005
15
Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries.
Petronella H Geelhoed-Duijvestijn, Ulrik Pedersen-Bjergaard, Raimund Weitgasser, Jorma Lahtela, Marie Markert Jensen, Claes-Göran Östenson. J Med Econ 2013
Petronella H Geelhoed-Duijvestijn, Ulrik Pedersen-Bjergaard, Raimund Weitgasser, Jorma Lahtela, Marie Markert Jensen, Claes-Göran Östenson. J Med Econ 2013
35
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials.
R E Ratner, S C L Gough, C Mathieu, S Del Prato, B Bode, H Mersebach, L Endahl, B Zinman. Diabetes Obes Metab 2013
R E Ratner, S C L Gough, C Mathieu, S Del Prato, B Bode, H Mersebach, L Endahl, B Zinman. Diabetes Obes Metab 2013
15
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes.
Ruth E Davis, Malcolm Morrissey, John R Peters, Kim Wittrup-Jensen, Tessa Kennedy-Martin, Craig J Currie. Curr Med Res Opin 2005
Ruth E Davis, Malcolm Morrissey, John R Peters, Kim Wittrup-Jensen, Tessa Kennedy-Martin, Craig J Currie. Curr Med Res Opin 2005
14
Severe hypoglycemia and risks of vascular events and death.
Sophia Zoungas, Anushka Patel, John Chalmers, Bastiaan E de Galan, Qiang Li, Laurent Billot, Mark Woodward, Toshiharu Ninomiya, Bruce Neal, Stephen MacMahon,[...]. N Engl J Med 2010
Sophia Zoungas, Anushka Patel, John Chalmers, Bastiaan E de Galan, Qiang Li, Laurent Billot, Mark Woodward, Toshiharu Ninomiya, Bruce Neal, Stephen MacMahon,[...]. N Engl J Med 2010
14
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
L A Donnelly, A D Morris, B M Frier, J D Ellis, P T Donnan, R Durrant, M M Band, G Reekie, G P Leese. Diabet Med 2005
L A Donnelly, A D Morris, B M Frier, J D Ellis, P T Donnan, R Durrant, M M Band, G Reekie, G P Leese. Diabet Med 2005
13
Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.
M Peyrot, A H Barnett, L F Meneghini, P-M Schumm-Draeger. Diabet Med 2012
M Peyrot, A H Barnett, L F Meneghini, P-M Schumm-Draeger. Diabet Med 2012
13
Understanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization.
Meryl Brod, Michael Wolden, Torsten Christensen, Donald M Bushnell. Value Health 2013
Meryl Brod, Michael Wolden, Torsten Christensen, Donald M Bushnell. Value Health 2013
29
Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study.
K Khunti, S Alsifri, R Aronson, M Cigrovski Berković, C Enters-Weijnen, T Forsén, G Galstyan, P Geelhoed-Duijvestijn, M Goldfracht, H Gydesen,[...]. Diabetes Obes Metab 2016
K Khunti, S Alsifri, R Aronson, M Cigrovski Berković, C Enters-Weijnen, T Forsén, G Galstyan, P Geelhoed-Duijvestijn, M Goldfracht, H Gydesen,[...]. Diabetes Obes Metab 2016
13
Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources.
S R Heller, B M Frier, M L Hersløv, J Gundgaard, S C L Gough. Diabet Med 2016
S R Heller, B M Frier, M L Hersløv, J Gundgaard, S C L Gough. Diabet Med 2016
23
12
A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function.
M Brod, M Wolden, T Christensen, D M Bushnell. Diabetes Obes Metab 2013
M Brod, M Wolden, T Christensen, D M Bushnell. Diabetes Obes Metab 2013
25
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
11
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
Andrew J Palmer, Stéphane Roze, William J Valentine, Michael E Minshall, Volker Foos, Francesco M Lurati, Morten Lammert, Giatgen A Spinas. Curr Med Res Opin 2004
Andrew J Palmer, Stéphane Roze, William J Valentine, Michael E Minshall, Volker Foos, Francesco M Lurati, Morten Lammert, Giatgen A Spinas. Curr Med Res Opin 2004
11
Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians.
Meryl Brod, Azhar Rana, Anthony H Barnett. Curr Med Res Opin 2012
Meryl Brod, Azhar Rana, Anthony H Barnett. Curr Med Res Opin 2012
26
A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education.
Diane Wild, Robyn von Maltzahn, Elaine Brohan, Torsten Christensen, Per Clauson, Linda Gonder-Frederick. Patient Educ Couns 2007
Diane Wild, Robyn von Maltzahn, Elaine Brohan, Torsten Christensen, Per Clauson, Linda Gonder-Frederick. Patient Educ Couns 2007
10
Non-severe nocturnal hypoglycemic events: experience and impacts on patient functioning and well-being.
Meryl Brod, Betsy Pohlman, Michael Wolden, Torsten Christensen. Qual Life Res 2013
Meryl Brod, Betsy Pohlman, Michael Wolden, Torsten Christensen. Qual Life Res 2013
22
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.
Craig J Currie, Christopher Ll Morgan, Chris D Poole, Peter Sharplin, Morten Lammert, Phil McEwan. Curr Med Res Opin 2006
Craig J Currie, Christopher Ll Morgan, Chris D Poole, Peter Sharplin, Morten Lammert, Phil McEwan. Curr Med Res Opin 2006
10
Increased mortality of patients with diabetes reporting severe hypoglycemia.
Rozalina G McCoy, Holly K Van Houten, Jeanette Y Ziegenfuss, Nilay D Shah, Robert A Wermers, Steven A Smith. Diabetes Care 2012
Rozalina G McCoy, Holly K Van Houten, Jeanette Y Ziegenfuss, Nilay D Shah, Robert A Wermers, Steven A Smith. Diabetes Care 2012
10
Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs.
Carrie Fidler, Torsten Elmelund Christensen, Samantha Gillard. J Med Econ 2011
Carrie Fidler, Torsten Elmelund Christensen, Samantha Gillard. J Med Econ 2011
10
Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies.
Chloe L Edridge, Alison J Dunkley, Danielle H Bodicoat, Tanith C Rose, Laura J Gray, Melanie J Davies, Kamlesh Khunti. PLoS One 2015
Chloe L Edridge, Alison J Dunkley, Danielle H Bodicoat, Tanith C Rose, Laura J Gray, Melanie J Davies, Kamlesh Khunti. PLoS One 2015
10
Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.
Chantal Mathieu, Priscilla Hollander, Bresta Miranda-Palma, John Cooper, Edward Franek, David Russell-Jones, Jens Larsen, Søren Can Tamer, Stephen C Bain. J Clin Endocrinol Metab 2013
Chantal Mathieu, Priscilla Hollander, Bresta Miranda-Palma, John Cooper, Edward Franek, David Russell-Jones, Jens Larsen, Søren Can Tamer, Stephen C Bain. J Clin Endocrinol Metab 2013
9
How hypoglycaemia can affect the life of a person with diabetes.
Brian M Frier. Diabetes Metab Res Rev 2008
Brian M Frier. Diabetes Metab Res Rev 2008
9
Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).
Bernard Zinman, Athena Philis-Tsimikas, Bertrand Cariou, Yehuda Handelsman, Helena W Rodbard, Thue Johansen, Lars Endahl, Chantal Mathieu. Diabetes Care 2012
Bernard Zinman, Athena Philis-Tsimikas, Bertrand Cariou, Yehuda Handelsman, Helena W Rodbard, Thue Johansen, Lars Endahl, Chantal Mathieu. Diabetes Care 2012
9
The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes.
Luigi Meneghini, Stephen L Atkin, Stephen C L Gough, Itamar Raz, Lawrence Blonde, Marina Shestakova, Stephen Bain, Thue Johansen, Kamilla Begtrup, Kåre I Birkeland. Diabetes Care 2013
Luigi Meneghini, Stephen L Atkin, Stephen C L Gough, Itamar Raz, Lawrence Blonde, Marina Shestakova, Stephen Bain, Thue Johansen, Kamilla Begtrup, Kåre I Birkeland. Diabetes Care 2013
9
The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review.
S Barendse, H Singh, B M Frier, J Speight. Diabet Med 2012
S Barendse, H Singh, B M Frier, J Speight. Diabet Med 2012
9
Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK.
M Evans, M Wolden, J Gundgaard, B Chubb, T Christensen. J Med Econ 2015
M Evans, M Wolden, J Gundgaard, B Chubb, T Christensen. J Med Econ 2015
30
Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes.
Lisa Elliott, Carrie Fidler, Andrea Ditchfield, Trine Stissing. Diabetes Ther 2016
Lisa Elliott, Carrie Fidler, Andrea Ditchfield, Trine Stissing. Diabetes Ther 2016
10
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser. Lancet 2016
Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser. Lancet 2016
9
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
9
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
Alan J Garber, Allen B King, Stefano Del Prato, Seamus Sreenan, Mustafa K Balci, Manuel Muñoz-Torres, Julio Rosenstock, Lars A Endahl, Ann Marie Ocampo Francisco, Priscilla Hollander. Lancet 2012
Alan J Garber, Allen B King, Stefano Del Prato, Seamus Sreenan, Mustafa K Balci, Manuel Muñoz-Torres, Julio Rosenstock, Lars A Endahl, Ann Marie Ocampo Francisco, Priscilla Hollander. Lancet 2012
8
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
Simon Heller, John Buse, Miles Fisher, Satish Garg, Michel Marre, Ludwig Merker, Eric Renard, David Russell-Jones, Areti Philotheou, Ann Marie Ocampo Francisco,[...]. Lancet 2012
Simon Heller, John Buse, Miles Fisher, Satish Garg, Michel Marre, Ludwig Merker, Eric Renard, David Russell-Jones, Areti Philotheou, Ann Marie Ocampo Francisco,[...]. Lancet 2012
8
Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes.
T Heise, L Nosek, S G Bøttcher, H Hastrup, H Haahr. Diabetes Obes Metab 2012
T Heise, L Nosek, S G Bøttcher, H Hastrup, H Haahr. Diabetes Obes Metab 2012
8
Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin - from the UK health care cost perspective.
M Evans, M Wolden, J Gundgaard, B Chubb, T Christensen. Diabetes Obes Metab 2014
M Evans, M Wolden, J Gundgaard, B Chubb, T Christensen. Diabetes Obes Metab 2014
22
Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk.
Elaine Chow, Alan Bernjak, Scott Williams, Robert A Fawdry, Steve Hibbert, Jenny Freeman, Paul J Sheridan, Simon R Heller. Diabetes 2014
Elaine Chow, Alan Bernjak, Scott Williams, Robert A Fawdry, Steve Hibbert, Jenny Freeman, Paul J Sheridan, Simon R Heller. Diabetes 2014
8
Validation of the IMS CORE Diabetes Model.
Phil McEwan, Volker Foos, James L Palmer, Mark Lamotte, Adam Lloyd, David Grant. Value Health 2014
Phil McEwan, Volker Foos, James L Palmer, Mark Lamotte, Adam Lloyd, David Grant. Value Health 2014
8
Validation of the CORE Diabetes Model against epidemiological and clinical studies.
Andrew J Palmer, Stéphane Roze, William J Valentine, Michael E Minshall, Volker Foos, Francesco M Lurati, Morten Lammert, Giatgen A Spinas. Curr Med Res Opin 2004
Andrew J Palmer, Stéphane Roze, William J Valentine, Michael E Minshall, Volker Foos, Francesco M Lurati, Morten Lammert, Giatgen A Spinas. Curr Med Res Opin 2004
8
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
8
Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence.
Janice Ms Lopez, Kathy Annunziata, Robert A Bailey, Marcia Ft Rupnow, Donald E Morisky. Patient Prefer Adherence 2014
Janice Ms Lopez, Kathy Annunziata, Robert A Bailey, Marcia Ft Rupnow, Donald E Morisky. Patient Prefer Adherence 2014
13
Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States.
Volker Foos, Nebibe Varol, Bradley H Curtis, Kristina S Boye, David Grant, James L Palmer, Phil McEwan. J Med Econ 2015
Volker Foos, Nebibe Varol, Bradley H Curtis, Kristina S Boye, David Grant, James L Palmer, Phil McEwan. J Med Econ 2015
10
Cost of hypoglycemia in patients with Type 2 diabetes in Sweden.
Linus Jönsson, Björn Bolinder, Jonas Lundkvist. Value Health 2006
Linus Jönsson, Björn Bolinder, Jonas Lundkvist. Value Health 2006
8
Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.
Thomas Haak, Hélène Hanaire, Ramzi Ajjan, Norbert Hermanns, Jean-Pierre Riveline, Gerry Rayman. Diabetes Ther 2017
Thomas Haak, Hélène Hanaire, Ramzi Ajjan, Norbert Hermanns, Jean-Pierre Riveline, Gerry Rayman. Diabetes Ther 2017
8
10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
8
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.